High rates of the SDHB p.Arg46Gln pathogenic variant predisposes New Zealand Māori to phaeochromocytoma/paraganglioma
- PMID: 36346292
- DOI: 10.1111/imj.15965
High rates of the SDHB p.Arg46Gln pathogenic variant predisposes New Zealand Māori to phaeochromocytoma/paraganglioma
Abstract
Background: Phaeochromocytomas (PCC) and paragangliomas (PGL; together PPGL) are rare tumours of the adrenal medulla or extra-adrenal paraganglia. They may secrete catecholamines with significant cardiovascular effects. Management of PPGL is predominantly surgical, despite the anaesthetic risks related to potential haemodynamic instability. Meticulous pre-treatment and intra-operative management are required to improve cardiovascular outcomes.
Aims: There are limited local data regarding the incidence of PPGL and the clinical characteristics of individuals diagnosed with these tumours in New Zealand. We undertook a retrospective study investigating the local practice and patient characteristics with an additional focus on intra-operative haemodynamic stability and post-operative outcomes.
Methods: Electronic patient records were searched for individuals with a diagnosis of PPGL. Clinical records and electronic databases were interrogated for pre-operative, intra-operative and post-operative data points. Particular attention was paid to rates and types of germline mutations, intra-operative haemodynamic stability and post-operative renal and cardiovascular outcomes.
Results: We identified 49 individuals with PPGL, of whom 34 were from the local area. This gave a local incidence of PPGL of around five cases per million people per year. Māori were significantly over-represented in our cohort, with this being in part due to high rates of the SDHB R46Q mutation. Over 95% of our cohort met pre-specified pre-operative blood pressure parameters. Intra-operative monitoring revealed a tendency to hypotension, but this did not translate into adverse post-operative outcomes, which were infrequent.
Conclusions: Māori were over-represented due to high rates of germline SDHB R46Q mutations. There were few post-operative adverse outcomes in this contemporary cohort.
Keywords: anaesthesia; haemodynamics; mutation; paraganglioma; phaeochromocytoma.
© 2022 Royal Australasian College of Physicians.
References
-
- Lenders JWM, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005; 366: 665-75.
-
- Kiernan CM, Solórzano CC. Pheochromocytoma and paraganglioma. Surg Oncol Clin N Am 2016; 25: 119-38.
-
- Neumann HPH, William F, Young J, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med 2019; 381: 552-65.
-
- Naranjo J, Dodd S, Martin YN. Perioperative management of pheochromocytoma. J Cardiothorac Vac Anesth 2017; 31: 1427-39.
-
- Groeben H, Nottebaum BJ, Greenwald A, Schumann R, Hollmann MW, Schwarte L et al. International multicentre review of perioperative management and outcome for catecholamine-producing tumours. Br J Surg 2020; 107: e170-8.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
